Co-Authors
This is a "connection" page, showing publications co-authored by Edison Durigon and Rafael Machado.
Connection Strength
0.861
-
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections. Transfusion. 2021 05; 61(5):1447-1460.
Score: 0.233
-
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Mem Inst Oswaldo Cruz. 2020; 115:e200342.
Score: 0.227
-
COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion. 2021 08; 61(8):2295-2306.
Score: 0.060
-
Anti-A and SARS-CoV-2: an intriguing association. Vox Sang. 2021 May; 116(5):557-563.
Score: 0.058
-
Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion. 2021 04; 61(4):1181-1190.
Score: 0.058
-
Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report. Pediatr Infect Dis J. 2020 10; 39(10):e321-e324.
Score: 0.057
-
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Transfusion. 2020 12; 60(12):2938-2951.
Score: 0.056
-
UV-C (254 nm) lethal doses for SARS-CoV-2. Photodiagnosis Photodyn Ther. 2020 12; 32:101995.
Score: 0.056
-
Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR. Braz J Microbiol. 2020 Sep; 51(3):1117-1123.
Score: 0.056